Dr. Tapson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8700 Beverly Blvd
Los Angeles, CA 90048Phone+1 310-967-1884Fax+1 310-423-0120- Is this information wrong?
Education & Training
- Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1989
- Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1986
- Duke University HospitalInternship, Internal Medicine, 1982 - 1983
- Drexel University College of MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 2013 - 2025
- NC State Medical License 1982 - 2024
- FL State Medical License 2014 - 2020
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow, Royal College of Physicians Royal College of Physicians, 2010
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) Start of enrollment: 2000 Sep 01
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
- The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCRE...Jason Weatherald, Steven D Nathan, Steven J Cassady, James Tarver, Deborah J Levine, Chunqin Deng, Eric Shen, Manisit Das, Karim El-Kersh, Rahul G Argula, Hilary M DuB...> ;BMJ Open Respiratory Research. 2024 Mar 22
- 1 citationsEarly immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.Jacqueline M Leung, Michelle J Wu, Pouya Kheradpour, Chen Chen, Katherine A Drake, Gary Tong, Vanessa K Ridaura, Howard C Zisser, William A Conrad, Natalia Hudson, Jar...> ;Frontiers in Immunology. 2024 Jan 1
- The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.Azizad, P., Mirocha, J., Karpov, O., Van Eyk, J., Marbán, E., Lewis, M., Shapiro, S., Oudiz, R., Nakamura, M., Geft, D., Matusov, Y., Hage, A., Tapson, V., Henry, T., ...> ;Ebiomedicine. 2024 Feb 1
- Join now to see all
Journal Articles
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine
- Remdesivir for the Treatment of Covid-19 — Final ReportAneesh K Mehta, Barry S Zingman, Andre C Kalil, Helen Y Chu, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Daniel A Sweeney, Willia..., The New England Journal of Medicine
- Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsGeoffrey D Barnes, Thomas M Todoran, Victor Tapson, Christopher Kabrhel, JAMA Network Open
Other
- Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosisTapson VF
http://www.uptodate.com/contents/fibrinolytic-thrombolytic-therapy-in-acute-pulmonary-embolism-and-l
UpToDate, Wolters Kluwer Health - 2012-11-29 - Treatment of acute pulmonary embolismTapson VF
http://www.uptodate.com/contents/treatment-of-acute-pulmonary-embolism
UpToDate, Wolters Kluwer Health - 2012-12-07
Authored Content
- Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsAugust 2020
- Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsAugust 2020
Press Mentions
- Researchers Introduce First Artificial Intelligence Tool to Detect COVID-19 ProbabilityDecember 13th, 2020
- Study Details First Artificial Intelligence Tool to Help Labs Rule-Out Covid-19 #ThelatestnewsDecember 11th, 2020
- Study Details First Artificial Intelligence Tool to Help Labs Rule-Out COVID-19December 10th, 2020
- Join now to see all
Grant Support
- Prospective Investigation Of Pulmonary Embolism Dx-IiNational Heart, Lung, And Blood Institute2000–2003
Industry Relationships
- VP of Medical Affairs, Inari MedicalWorking with this novel and progressive company to help move the field of VTE treatment ahead. I continue seeing patients with pulmonary embolism at Cedars-Sinai in Los Angeles.2021 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: